Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,343.72
(
0.00%
)
US TECH 100
22,570.00
(
1.07%
)
Dow Jones
45,216.14
(
0.00%
)
Brent Oil
107.55
(
-0.94%
)
Bitcoin
66,762.67
(
0.09%
)
News Focus
News Focus
Post# of 257314
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122824
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 133489

Wednesday, 12/21/2011 1:44:30 PM

Wednesday, December 21, 2011 1:44:30 PM

Post# of 257314
Today is a busy day for AZN business development. Here are two additional items:

• AstraZeneca Enters into Option Agreement to Acquire New Class of Diabetes Assets from Prosidion (http://www.astrazeneca.com/Research/news/Article/20111221--astrazeneca-enters-into-option )

• AstraZeneca and Chi-Med enter into global collaboration to co-develop and commercialise novel cancer therapy
• (http://www.astrazeneca.com/Research/news/Article/20111221az-and-chimed-enter )

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today